IGEA Pharma N.V. becomes the 12th new listing at SIX in 2018

Today, the shares of IGEA Pharma N.V. (IGPH) were listed under the “International Reporting Standard” on the Swiss Stock Exchange.

Published at
Medium
Media

The share capital of IGEA Pharma N.V. comprises 25,048,769 shares with a nominal value of EUR 0.01 each. The opening price was CHF 3.75 per share, corresponding to a market capitalization of around CHF 94 million. An offering of the company’s shares has not taken place.

IGEA Pharma N.V. is a life sciences company with its corporate headquarters in Amsterdam in the Netherlands. The IGEA Group focuses on products and services related to the prevention of Alzheimer's and Type II Diabetes. For more information on the company, please visit: www.igeapharma.nl

Any questions?

Please do not hesitate to contact Julian Chan.

Generate PDF

 
About SIX
SIX operates and develops infrastructure services for the Swiss and Spanish Stock Exchanges, for Post-Trade Services, Banking Services and Financial Information with the aim of raising efficiency, quality and innovative capacity across the entire value chain of the Swiss and Spanish financial centers. The company is owned by its users (120 banks). With a workforce of 4,044 employees and a presence in 20 countries, it generated operating income of CHF 1.5 billion and Group net profit of CHF 185.0 million in 2022.
www.six-group.com

View all Media Releases